1. Towards defining and reducing the risk of chemotherapy-related leukaemia

   Newsletter Article 27 January 2013 Pages: 1 - 1

2. A link exists between valproic acid and spina bifida

   Newsletter Article 27 January 2013 Pages: 1 - 1

3. Ranitidine may cause blood dyscrasias

   Newsletter Article 27 January 2013 Pages: 2 - 2

4. Please be upstanding for doxycycline capsules

   Newsletter Article 27 January 2013 Pages: 2 - 2

5. Be aware of possible hair loss

   Newsletter Article 27 January 2013 Pages: 2 - 3

6. Rapid and prolonged IV infusions of tiazofurin should be avoided

   Newsletter Article 27 January 2013 Pages: 3 - 3

7. ACE inhibitor poisoning

   Newsletter Article 27 January 2013 Pages: 3 - 3

8. Amphotericin B

   Newsletter Article 27 January 2013 Pages: 3 - 4

9. Ampicillin

   Newsletter Article 27 January 2013 Pages: 4 - 4

10. Anaesthetics

    Newsletter Article 27 January 2013 Pages: 4 - 4

11. Antithyroids

    Newsletter Article 27 January 2013 Pages: 4 - 4

12. Botulinum toxin

    Newsletter Article 27 January 2013 Pages: 4 - 4

13. Bumetanide

    Newsletter Article 27 January 2013 Pages: 4 - 5

14. Captopril

    Newsletter Article 27 January 2013 Pages: 5 - 5

15. Cisplatin

    Newsletter Article 27 January 2013 Pages: 5 - 5

16. Cotrimoxazole + sulfacetamide

    Newsletter Article 27 January 2013 Pages: 5 - 5

17. Digoxin interaction

    Newsletter Article 27 January 2013 Pages: 5 - 5

18. Dihydrocodeine

    Newsletter Article 27 January 2013 Pages: 5 - 5

19. Diltiazem

    Newsletter Article 27 January 2013 Pages: 5 - 5

20. Dinoprostone

    Newsletter Article 27 January 2013 Pages: 5 - 6

21. Doxepin see Imipramine/maprotiline/doxepin

    Newsletter Article 27 January 2013 Pages: 6 - 6

22. Enalapril

    Newsletter Article 27 January 2013 Pages: 6 - 6

23. Fenbufen see Sulindac/fenbufen

    Newsletter Article 27 January 2013 Pages: 6 - 6

24. Fluoxetine

    Newsletter Article 27 January 2013 Pages: 6 - 6

25. Fluoxetine interaction

    Newsletter Article 27 January 2013 Pages: 6 - 6

26. Germanium

    Newsletter Article 27 January 2013 Pages: 6 - 7

27. Imipramine/maprotiline/doxepin

    Newsletter Article 27 January 2013 Pages: 7 - 7

28. Immunoglobulin G abuse

    Newsletter Article 27 January 2013 Pages: 7 - 7

29. Interleukin 2

    Newsletter Article 27 January 2013 Pages: 7 - 7

30. Maprotiline see Imipramine/maprotiline/doxepin

    Newsletter Article 27 January 2013 Pages: 7 - 7

31. Medroxyprogesterone

    Newsletter Article 27 January 2013 Pages: 7 - 7

32. Ofloxacin

    Newsletter Article 27 January 2013 Pages: 7 - 7

33. Pentazocine see Fluoxetine interaction

    Newsletter Article 27 January 2013 Pages: 7 - 7

34. Prednisolone

    Newsletter Article 27 January 2013 Pages: 7 - 7

35. Prednisone

    Newsletter Article 27 January 2013 Pages: 7 - 7

36. Ritodrine

    Newsletter Article 27 January 2013 Pages: 7 - 7

37. Sulfacetamide see Cotrimoxazole + sulfacetamide

    Newsletter Article 27 January 2013 Pages: 7 - 7

38. Sulindac/fenbufen

    Newsletter Article 27 January 2013 Pages: 8 - 8

39. Tacrine

    Newsletter Article 27 January 2013 Pages: 8 - 8

40. Tryptophan

    Newsletter Article 27 January 2013 Pages: 8 - 8

41. Vancomycin

    Newsletter Article 27 January 2013 Pages: 8 - 8

42. Verapamil see Digoxin interaction

    Newsletter Article 27 January 2013 Pages: 8 - 8